Altimmune Inc (NASDAQ: ALT) — Healthcare · Share Price, Chart & Market Data
About: Altimmune, Inc., a late clinical stage biopharmaceutical company, focuses on developing novel therapies for serious liver diseases. Its lead product candidate is pemvidutide, a GLP-1/glucagon dual receptor agonist, which is in Phase 3 clinical trial for the treatment of metabolic dysfunction-associated steatohepatitis, alcohol use disorder, and alcohol-associated liver disease. The company was founded in 1997 and is headquartered in Gaithersburg, Maryland.
Sector: Healthcare
Industry: Biotechnology
Latest price: $2.85 (-1.38%)
ALTAltimmune Inc
Loading watchlist status…
Trade ALT now
Altimmune Inc share price
ALT price activity
Last Price
Change (24hr)
USD (%)
Volume
Volume (4w avg)
Previous Close
N/A
Last Trade
Delayed
27 Apr, 8:59 am GMT+0
ALT price performance
-19.944%
5D
-12.037%
1M
-18.803%
YTD
-44.874%
1Y
ALT price fundamentals
N/A
Shares Issued
N/A
Dividends Per Share (DPS)
N/A
Earnings Per Share (EPS)
N/A
P/E Ratio
Price market cap
Market cap
N/A
NASDAQ rank
N/A
Sector Rank
N/A
Delayed
27 Apr, 8:59 am GMT+0
ALT Market Signals